These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6763142)

  • 41. [Current aspects of the problem of arterial hypertension].
    Shkhvatsabaia IK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):6-11. PubMed ID: 3011030
    [No Abstract]   [Full Text] [Related]  

  • 42. [The central nervous system in hypertension].
    Brody MJ
    Medicina (B Aires); 1979; 39 Suppl 1():29-34. PubMed ID: 550055
    [No Abstract]   [Full Text] [Related]  

  • 43. Modification of sympathetic transmission by antihypertensive agents.
    Bender AD
    Del Med J; 1966 Aug; 38(8):229-34. PubMed ID: 5968951
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.
    Reaven GM; Lithell H; Landsberg L
    N Engl J Med; 1996 Feb; 334(6):374-81. PubMed ID: 8538710
    [No Abstract]   [Full Text] [Related]  

  • 45. [New viewpoints on the treatment of hypersensitivity. With comments on the pathogenesis of essential hypertension].
    Werning C
    Med Klin; 1974 Jun; 69(25):1087-99. PubMed ID: 4602392
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacological basis for antihypertensive therapy with a novel dopamine agonist.
    Haeusler G; Lues I; Minck KO; Schelling P; Seyfried CA
    Eur Heart J; 1992 Sep; 13 Suppl D():129-35. PubMed ID: 1356783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transmission of the sympathetic nervous impulse during pregnancy.
    Castrén ; Olli ; Saarikoski ; Seppo ; Siimes ; Anja
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:47. PubMed ID: 4330574
    [No Abstract]   [Full Text] [Related]  

  • 48. [Functional status of the sympathetic nervous system in patients with essential hypertension and low as well as normal plasma renin].
    Philipp T; Planz J; Schumann G; Lindmar R; Distler A
    Verh Dtsch Ges Inn Med; 1974; 80():253-6. PubMed ID: 4454537
    [No Abstract]   [Full Text] [Related]  

  • 49. Sympathetic nerve activity in low renin essential hypertension.
    Iimura O; Shoji T; Okada T; Miyama A; Kijima T; Yoshida S; Imai M; Kondo A; Miyahara M
    Jpn Circ J; 1979 Sep; 43(9):870-81. PubMed ID: 501906
    [No Abstract]   [Full Text] [Related]  

  • 50. [The control of renin secretion: experimental data and clinical implications].
    Zanchetti A; Leonetti G; Morganti A; Terzoli L; Stella A
    Atti Soc Ital Cardiol; 1978; 37():46-59. PubMed ID: 356832
    [No Abstract]   [Full Text] [Related]  

  • 51. Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.
    Dudenbostel T; Siddiqui M; Oparil S; Calhoun DA
    Hypertension; 2016 Jun; 67(6):1085-92. PubMed ID: 27091893
    [No Abstract]   [Full Text] [Related]  

  • 52. High and low renin subgroups of essential hypertension: differences and similarities in their renin and sympathetic responses to neural and nonneural stimuli.
    Morganti A; Pickering TG; Lopez-Ovejero JA; Laragh JH
    Am J Cardiol; 1980 Aug; 46(2):306-12. PubMed ID: 6996468
    [No Abstract]   [Full Text] [Related]  

  • 53. [Role of the adrenergic sympathetic system and diagnostic and therapeutic reflections].
    Valori C; Biancifiori M; Pinchi G; Agabiti-Rosei E
    Atti Soc Ital Cardiol; 1978; 37():29-45. PubMed ID: 687231
    [No Abstract]   [Full Text] [Related]  

  • 54. [Correlations between plasmatic renin and aldosterone in essential arterial hypertension with sympathetic hyperactivity].
    Pirrelli A; Pieri R; Dolce E
    Boll Soc Ital Cardiol; 1976; 21(3):511-5. PubMed ID: 1031016
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of the sympathetic nervous system in mediating the renin response to head-up tilt. Their possible synergism in defending blood pressure against postural changes during sodium deprivation.
    Morganti A; Lopez-Ovejero JA; Pickering TG; Laragh JH
    Am J Cardiol; 1979 Mar; 43(3):600-4. PubMed ID: 420109
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin].
    Os I; Kjeldsen SE; Beckmann SL; Eide I; Hjermann I; Leren P; Westheim A
    Tidsskr Nor Laegeforen; 1987 Apr; 107(10-11):954-7. PubMed ID: 3299859
    [No Abstract]   [Full Text] [Related]  

  • 57. [The variability of 24-hour blood pressure and the affecting factors].
    Hano T; Nakamura C; Nishio I
    Nihon Rinsho; 1992 May; 50 Suppl():314-9. PubMed ID: 1512970
    [No Abstract]   [Full Text] [Related]  

  • 58. Essential hypertension: are catecholamines involved? Introduction.
    Lake CR
    Fed Proc; 1984 Jan; 43(1):45-6. PubMed ID: 6690336
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neurogenic factors and hypertension].
    Taquini AC; Martínez Seeber A
    Medicina (B Aires); 1974; 34(5):547-55. PubMed ID: 4373634
    [No Abstract]   [Full Text] [Related]  

  • 60. [Mechanisms of sympathetic function inhibition and its importance in the treatment of hypertension].
    Muscholl E
    Internist (Berl); 1966 Aug; 7(8):405-13. PubMed ID: 4863413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.